Search details
1.
Synthetical lethality of Werner helicase and mismatch repair deficiency is mediated by p53 and PUMA in colon cancer.
Proc Natl Acad Sci U S A
; 119(51): e2211775119, 2022 12 20.
Article
in English
| MEDLINE | ID: mdl-36508676
2.
Increased AXLhigh myeloid cells as pathognomonic marker in Langerhans cell histiocytosis and Langerin expression dependence of mTOR inhibition.
Clin Immunol
; 263: 110203, 2024 Jun.
Article
in English
| MEDLINE | ID: mdl-38575046
3.
Immunoregulatory effects of Lurbinectedin in chronic lymphocytic leukemia.
Cancer Immunol Immunother
; 69(5): 813-824, 2020 May.
Article
in English
| MEDLINE | ID: mdl-32055920
4.
Chronic lymphocytic leukemia cells increase neutrophils survival and promote their differentiation into CD16high CD62Ldim immunosuppressive subset.
Int J Cancer
; 144(5): 1128-1134, 2019 03 01.
Article
in English
| MEDLINE | ID: mdl-30178523
5.
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).
Cancer Immunol Immunother
; 66(1): 77-89, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27796477
6.
The kinase inhibitors R406 and GS-9973 impair T cell functions and macrophage-mediated anti-tumor activity of rituximab in chronic lymphocytic leukemia patients.
Cancer Immunol Immunother
; 66(4): 461-473, 2017 Apr.
Article
in English
| MEDLINE | ID: mdl-28011996
7.
Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia.
Haematologica
; 105(9): e465-469, 2020 09 01.
Article
in English
| MEDLINE | ID: mdl-33054065
8.
Autologous T-cell activation fosters ABT-199 resistance in chronic lymphocytic leukemia: rationale for a combined therapy with SYK inhibitors and anti-CD20 monoclonal antibodies.
Haematologica
; 103(10): e458-e461, 2018 10.
Article
in English
| MEDLINE | ID: mdl-29748439
9.
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.
Haematologica
; 102(7): e257-e260, 2017 07.
Article
in English
| MEDLINE | ID: mdl-28360148
10.
CDK4/6 Inhibition Suppresses p73 Phosphorylation and Activates DR5 to Potentiate Chemotherapy and Immune Checkpoint Blockade.
Cancer Res
; 82(7): 1340-1352, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-35149588
11.
BET protein degradation triggers DR5-mediated immunogenic cell death to suppress colorectal cancer and potentiate immune checkpoint blockade.
Oncogene
; 40(48): 6566-6578, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34615996
12.
Non-steroidal anti-inflammatory drugs induce immunogenic cell death in suppressing colorectal tumorigenesis.
Oncogene
; 40(11): 2035-2050, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33603166
13.
The effect of ibrutinib on neutrophil and γδ T cell functions.
Leuk Lymphoma
; 61(10): 2409-2418, 2020 10.
Article
in English
| MEDLINE | ID: mdl-32306816
14.
Editorial: Myeloid cell reprogramming: molecular pathways involved in disease development.
Front Immunol
; 15: 1414482, 2024.
Article
in English
| MEDLINE | ID: mdl-38745655
15.
Revisiting the role of interleukin-8 in chronic lymphocytic leukemia.
Sci Rep
; 7(1): 15714, 2017 Nov 16.
Article
in English
| MEDLINE | ID: mdl-29146966
16.
Neglected players: Tumor associated neutrophils involvement in chronic lymphocytic leukemia progression.
Oncotarget
; 10(20): 1862-1863, 2019 Mar 08.
Article
in English
| MEDLINE | ID: mdl-30956765
17.
Effect of the BTK inhibitor ibrutinib on macrophage- and γδ T cell-mediated response against Mycobacterium tuberculosis.
Blood Cancer J
; 8(11): 100, 2018 11 05.
Article
in English
| MEDLINE | ID: mdl-30397191
18.
Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells
Haematologica
; 102: [4 p.], 2017. tab
Article
in English
| URUCAN | ID: bcc-5224
Results
1 -
18
de 18
1
Next >
>>